One expert believes the lack of standardization for how diagnostic imaging in conducted and reported has led to a major underdiagnosis of HCM.

Roberts was a passionate cardiac pathologist known for his focus and determination. “To say Bill Roberts will be missed is a massive understatement,” one colleague said. 

Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up. 

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained. 

The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians. 

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.